Chief Business Officer @ (September 2013 - September 2015)
Vice President, Corporate Strategy and Development @ Millennium Pharmaceuticals: The Takeda Oncology Company (March 2002 - September 2013)
Summer Intern @ Pfizer (January 1999 - January 1999)
Consultant @ TQM Group / Spire (January 1993 - January 1995)
Kyle Kuvalanka Education
The Wharton School of Business, University of Pennsylvania
MBA (Strategy, Finance)
1998-2000
Wesleyan University
BA (College of Social Studies)
1986-1990
Kyle Kuvalanka Skills
Sales
Research
Strategic Planning
PowerPoint
Customer Service
Microsoft Office
Investor Relations
Fellow
Strategic Partnerships
Drug Discovery
Kyle Kuvalanka Summary
Kyle Kuvalanka, based in Boston, MA, US, is currently a Chief Financial Officer at Aktis Oncology. Kyle Kuvalanka brings experience from previous roles at ROME Therapeutics, Self-employed, Goldfinch Bio and Third Rock Ventures. Kyle Kuvalanka holds a 1998 - 2000 MBA in Strategy, Finance @ The Wharton School of Business, University of Pennsylvania. With a robust skill set that includes Sales, Research, Strategic Planning, PowerPoint, Customer Service and more. Kyle Kuvalanka has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kyle Kuvalanka?
Find contact details for 700 million professionals.